Anticoagulation Length in Cancer Associated Thrombosis
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This is a two year, multicentre, mixed methods feasibility study including a randomised
controlled two-arm interventional trial, a nested qualitative study, focus groups and a
United Kingdom (UK) wide survey exercise.
Phase:
Phase 2
Details
Lead Sponsor:
Cardiff University
Collaborators:
National Institute for Health Research, United Kingdom Wales Cancer Trials Unit